Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Purchase | 2024-02-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 348,691 9.545% | 38,310 (+12.34%) | Filing History |
| 2023-10-19 3:33 pm Purchase | 2023-10-11 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 244,289 6.700% | 244,289 (New Position) | Filing History |
| 2023-09-21 4:52 pm Sale | 2023-08-04 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 182,426 5.200% | -12,760 (-6.54%) | Filing History |
| 2023-09-14 4:21 pm Purchase | 2023-08-04 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 195,186 5.500% | 33,779 (+20.93%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Ikena Oncology, Inc. IKNA | Citadel Advisors LLC | 179,595 5.900% | 2,244 (+1.27%) | Filing History |
| 2023-02-13 6:11 pm Purchase | 2022-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 208,589 6.900% | 58,725 (+39.19%) | Filing History |
| 2023-01-10 12:48 pm Purchase | 2023-01-09 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 310,381 10.272% | 99,864 (+47.44%) | Filing History |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 210,517 6.967% | -183,124 (-46.52%) | Filing History |
| 2022-02-14 2:57 pm Purchase | 2021-12-31 | 13G | Ikena Oncology, Inc. IKNA | Omega Fund VI, L.P. | 187,427 6.300% | 187,427 (New Position) | Filing History |
| 2022-02-14 1:35 pm Purchase | 2021-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 149,864 5.000% | 16,559 (+12.42%) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Ikena Oncology, Inc. IKNA | Citadel Advisors LLC | 177,351 5.900% | 6,105 (+3.56%) | Filing History |
| 2022-02-11 5:12 pm Purchase | 2021-03-30 | 13D | Ikena Oncology, Inc. IKNA | Atlas Venture Fund X, L.P. | 241,801 8.100% | 241,801 (New Position) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 393,641 13.155% | 78,837 (+25.04%) | Filing History |
| 2021-08-16 4:45 pm Unchanged | 2021-08-12 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 161,407 5.400% | 0 (Unchanged) | Filing History |
| 2021-04-14 7:31 pm Purchase | 2021-03-30 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 161,407 6.560% | 161,407 (New Position) | Filing History |
| 2021-04-12 1:05 pm Purchase | 2021-04-09 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 314,803 12.541% | 314,803 (New Position) | Filing History |
| 2021-04-09 4:57 pm Purchase | 2021-03-30 | 13G | Ikena Oncology, Inc. IKNA | Citadel Advisors LLC | 171,246 6.600% | 171,246 (New Position) | Filing History |
| 2021-04-05 5:25 pm Purchase | 2021-03-25 | 13G | Ikena Oncology, Inc. IKNA | BRISTOL MYERS SQUIBB CO BMY | 177,762 5.900% | 177,762 (New Position) | Filing History |
| 2021-04-05 5:03 pm Purchase | 2021-03-26 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 133,305 5.100% | 133,305 (New Position) | Filing History |